Many doctors and cancer specialists believe vaccine technology could offer great hope and lead to an entirely new form of cancer treatment and cure. Cancer vaccines typically will have fewer side effects than current chemotherapy, radiotherapy or monoclonal antibody therapy and will improve the quality of life of cancer patients. There are a number of different areas of research currently being undertaken. The first cancer vaccine approved for treating cancer by the US and Europe authorities has shown promise but is very expensive ($93k per patient) and it is hard to produce consistently.
New technology is designed vaccines, which are defined cell lines, have been designed with characteristics that (i) make them very good at immunising and (ii) direct the immune system to attack key target molecules on the cancer cells. This is the type of design that the Trust is seeking to promote.